Application 215057
- Type
- ANDA
- Sponsor
- NEXUS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NELARABINE | NELARABINE | INJECTABLE;INTRAVENOUS | 250MG/50ML (5MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215057-001 | NELARABINE | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215057-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | 3f0d92c62455… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215057-001 | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2023-06-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215057-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215057-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A215057-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215057-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215057-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215057-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215057-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215057-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215057-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A215057-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215057-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215057-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215057-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A215057-001 | AP | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215057-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A215057-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A215057-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215057-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215057-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215057-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215057-001 | AP | 1 | 3f0d92c62455… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215057-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nelarabine | NELARABINE | Amneal Pharmaceuticals LLC | 8d0e1b59-bd1e-4c6e-9a95-e8143ee076bf | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| Nelarabine | NELARABINE | Meitheal Pharmaceuticals Inc | 21919314-5c25-49ab-beba-099983ed4a71 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| nelarabine | NELARABINE | Shorla Oncology Inc. | fc401b06-4e3b-413e-a854-3e031c433862 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | nelarabine NELARABINE |
| NELARABINE | NELARABINE | Alembic Pharmaceuticals Inc. | a2a08758-9a9d-49a2-a498-9da109045ee9 | 2025-07-08 | Boxed warning, Warnings, Adverse reactions | NELARABINE NELARABINE |
| Nelarabine | NELARABINE | Zydus Pharmaceuticals USA Inc. | 8cb23281-93ca-40b8-b8e0-c57dd4298322 | 2025-04-16 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| Nelarabine | NELARABINE | Gland Pharma Limited | 651bf4d2-75b0-4a60-8014-7006ffe61084 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| Nelarabine | NELARABINE | Zydus Pharmaceuticals USA Inc. | e425731e-626b-4141-a997-fb85e077c2a4 | 2025-04-07 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| Arranon | NELARABINE | Sandoz Inc | 0f9051de-5c4d-4c0f-8c19-e15214498cca | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | NELARABINE |
| Arranon | NELARABINE | Novartis Pharmaceuticals Corporation | fffa5d75-0dba-4ad7-a252-5f60fa28489a | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | NELARABINE |
| Nelarabine | NELARABINE | Dr. Reddy's Laboratories, Inc. | 57275b05-f40f-7298-5a5e-93594bc41437 | 2025-03-29 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| Nelarabine | NELARABINE | XGen Pharmaceuticals DJB, Inc. | a1cc1580-50d9-4b9b-a002-1fc6686a9515 | 2024-12-18 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| NELARABINE | NELARABINE | Alembic Pharmaceuticals Limited | 03ad6056-0e71-4e7c-842a-a5f87649bdcd | 2024-08-07 | Boxed warning, Warnings, Adverse reactions | NELARABINE NELARABINE |
| Nelarabine | NELARABINE | Sagent Pharmaceuticals | f60da70f-2f9e-421d-a277-95b1edb57a71 | 2024-05-28 | Boxed warning, Warnings, Adverse reactions | Nelarabine NELARABINE |
| NELARABINE | NELARABINE | Novadoz Pharmaceuticals LLC | d556a9e7-310b-41dc-99f8-a281fe7da3fe | 2023-05-16 | Boxed warning, Warnings, Adverse reactions | NELARABINE NELARABINE |
| Nelarabine | NELARABINE | Zydus Lifesciences Limited | 877b69a0-0899-455d-926e-f5a7478c31f8 | 2022-11-05 | Nelarabine NELARABINE |